View Article

  • Review On Film Forming Spray for Topical Drug Delivery

  • Department Of Pharmaceutics JSPM Sudhakarrao Naik Institute of Pharmacy Pusad. India 445204.

Abstract

In contrast to conventional topical preparations, film-forming sprays offer a number of benefits, such as uniform drug dosage and distribution, improved bioavailability, less irritation, continuous drug release, and accelerated wound healing via moisture management. In film-forming sprays, polymers and excipients improve preparation qualities and increase the stability of active components. All types of polymers and excipients will produce films with different characteristics. The different types of polymers and excipients, as well as their evaluation criteria, must be investigated in order to create a more suitable kind of film-forming spray. The selected literature included studies on the use of polymers as film-forming matrices and the potential medical applications of these sprays. In this article, we discuss the types and quantities of excipients and polymers, sprayer types, testing, and important aspects that determine the sprayability and film qualities. Both natural and synthetic polymers with in situ film or viscoelastic capabilities can be used to enhance topical medication administration, according to the review.

Keywords

film-forming solution, film-forming polymer, and topical drug delivery

Introduction

The human body's largest organ is the skin.  It offers defence against environmental consequences such as UV radiation, physical and chemical attacks, contact with dangerous microbes, and discomfort.  (3, 23) Due of its poor permeability to environmental micro and macromolecules, it also acts as a barrier against them.  Although transdermal drug delivery has greatly enhanced medical practice, it is still in its infancy as a substitute for oral medicine administration and hypodermic injections.  (4) The advantages of topical medication distribution include avoiding the effects of acidic environments and enzyme activity in the digestive system, making use of the vast amount of available skin surface, and avoiding initial metabolic processing. It is designed to have either localized or systemic effects.  (4) The stratum corneum, a protective layer of non-living, keratinized epidermal cells that is 10 micrometres thick, is the main route by which drugs are absorbed through the skin. (5) The process by which drugs move through the skin is referred to as drug permeation.  Therefore, it is difficult for drug molecules to get through the skin. (6) In order to enhance pharmacokinetic characteristics or therapeutic efficiency, topical drugs are frequently created as sprays, gels, creams, ointments, lotions, patches, or other dosing methods. (8) Sprays have several advantages over other topical doses, including being easy to apply, having a low chance of irritating the skin, being sterile, offering superior coverage for a wound or area, dispersing the drug uniformly when applied, and having a variable dosage. (10)  In contrast to traditional topical treatments, a thin, sticky film forms, which might prolong contact time and the drug's penetration capacity, resulting in a longer-lasting release of the medicine.  Additionally, by preventing crystallization, more of the drug may be available to offer therapeutic benefits.  (11) A novel technique known as FFS (film forming system) can replace conventional skin preparations and treatments that are absorbed by the skin.  Applying this type of liquid medication to the skin or another surface creates an in-situ film.  A film containing the medication and excipients is left behind after the carrier containing the medication and additives evaporates when it comes into contact with the skin.  A solid polymeric substance that serves as a drug release matrix for controlled drug delivery or a liquid that is rapidly absorbed by the stratum corneum 10 could be the resulting film.  (12). The methods used to build a controlled medication release FFS to improve therapeutic efficacy are discussed, as are the potential future developments of this technology in the pharmaceutical sector.  (12,70)

Methodology:

Human skin is composed of two primary layers: the epidermis and the dermis.  The stratum corneum, the outermost surface, is where the four layers of the epidermis are found.  (70)  The dermis, which lies beneath the epidermis, ensures the skin's suppleness and controls body temperature.  It is mostly composed of collagen and matrix-encased elastic fibers.  The dermis contains sensory nerves, lymphatic channels, and blood vessels.  The stratum corneum restricts the quantity of drug absorption based on its penetration ability.  Drugs can enter the stratum corneum through a variety of pathways, including trans-epidermal, trans-follicular, and trans-glandular.  The medicine and formulation determine how deeply they permeate the skin.

Mechanism:

The film-forming system is applied directly to the skin and forms a thin, transparent coating once the solvent evaporates.  The formulation undergoes a substantial change after being applied to the skin, creating a long-lasting layer on the skin's surface due to the evaporation of volatile components in the carrier.  During this phase, the concentration of the medication increases until it reaches saturation, and it may even approach supersaturation.  Through an improvement in the thermodynamic activity of the skin without compromising its protective barrier, supersaturation raises the drug flux.  This formulation won't produce irritation or adverse effects when applied.  (49, 55)  The explanation for supersaturation can be found in a modification of Fick's equation of diffusion.  Fick's law of diffusion is represented by the equation below:

J = DKCv/h

In this equation:

  • J stands for the rate of drug permeation (flux).
  • D represents the diffusion coefficient of the drug.
  • CV is the concentration of the drug.
  • H signifies the thickness of the barrier to diffusion.

This formula demonstrates the clear proportionality between medication concentration and skin penetration rate.  On the other hand, this occurs when the medication totally dissolves in the vehicle.  This equation shows a direct and obvious relationship between drug flux and the thermodynamic activity of the system, which is related to saturation.  (22).  Nevertheless, the thermodynamic instability rises with the supersaturation.  After skin application, FFS solves the instability issue by generating supersaturated systems.  In contrast to other transdermal administration methods, it therefore enhances drug penetration via the skin.  (68, 71)

Fig.1 Mechanism of film forming system

Different Type of Film-Forming Sprayers:

  1. Ordinal Spray:

Ordinal spraying is a type of spraying that usually employs a container made of plastic or aluminum that has an aperture size of 0.3 mm and a dip tube diameter of 1.2 mm.  When spraying, this type of spray doesn't require any specialized technology.  It is frequently possible to spray 0.11-0.35 g or - mL of film-forming solution, with an average angle of 78.69 87.39°. (24, 26)  The average leakage rate of a standard spray bottle is between 0.01 and 0.03%. (63,66)  34  Ordinal sprays can be either horizontal or vertical.  The 3 K® Horizontal Spray Nozzle is said to be able to maintain the sterility of the film-forming fluid during both storage and use.  The spray force of the ordinal spray is also influenced by the kind and concentration of polymer used.  (66).

  1. Metered Dose Spray:

The metered dosage spray (MDS) is one spraying device with a variable spray output.  This apparatus is typically used to administer medications via the transdermal or transmucosal routes to the systemic compartment.  Because the spray volume is related to the medicine dosage, it must be taken into account while evaluating a film-forming spray.  The amount of MDS that may be sprayed depends on the bottle's volume, the homogeneity of particle dispersion, and the container's position when in use.    Typically, 90 to 102 mL of FFS can be sprayed.  30, 32, and 33:  For MDS, the typical spray angle is 83.51°.  (22)  A MDS container's typical leakage rate ranges from 0.01 to 0.02%.  30. (67),

C. Electrostatic Spray:

One common technique for applying pesticides in agriculture is electrostatic spraying (ES).  Drift loss, droplet formation speed, cover-age uniformity, and deposition efficiency can all be improved by ES.  (75) The effectiveness of ES is influenced by the solution's electrical resistivity, surface tension, and viscosity.  (76).  A solution must have conductivity between 108 and 105 S/m in order to be sprayed with ES.  The typical droplet diameter produced by ES is between 6.3 and 26 meters.  (38).

D. Ultrasonic Spray:

There is great potential for using ultrasonic spray to provide film-forming solutions.  The resultant droplet can get close to the nanoscale and possesses thin film characteristics.  The ultrasonic spray nozzle produces consistent droplets with a diameter of less than 10 m and can function at both low and high pressures.  The nozzle of the ultrasonic spray has a diameter of 0.5 mm, and the droplet diameter ranges from 1 to 10 m.  The resonance frequency of the electrode in use is 10 MHz.  For medical applications, layer-by-layer (LBL) coating films with more homogeneous particle sizes can be created with an ultrasonic spray. (46) Each type of sprayer has specifications that match specific polymers.  A range of synthetic and natural polymers have been used in the FFS system.  (1)

Utilizations of Film-Forming Systems:

Film-forming technologies were first mostly used in the surgical and wound care industries.  These systems, which were used as surgical adhesives and were in gel or solution form, were used to seal surgical wounds.  For this purpose, the film-forming agents can be either natural materials like fibrin or manufactured compounds like cyanoacrylates.  These formulations for wound care were specifically designed to either be free of pharmaceutical chemicals or contain antimicrobial agents to help prevent infections in the wounds.  However, this technique is not limited to medical applications.  Non-medical applications include the use of silicone film forming technologies in cosmetics and the delivery of active compounds in cosmetics. formulations for cosmetic creams and ointments.  Additionally, it has been used in transparent peel-off masks for moisture-related skin acne treatments, among other things.  Additionally, the technique demonstrates the potential to serve as a base material for other protective membranes utilized in industrial settings.  In order to protect employees from exposure to chemicals such as cleansers, caustic materials, alkaline solutions, hazardous compounds, infrared heat, UV light, and the like, these protective membranes are essential.  Examples of this use include lotions and salves that are both water-attracting and water-repellent, as well as creams that are intended to protect against UV rays.  (27, 31) Film-forming solutions are the most widely used type of film-forming systems.  The primary ingredients are a volatile medium for the dissolution or dispersion of polymers, plasticizers, and other excipients.  (27, 31)

Fig 2: Film formation after application

Formulation Components for Film Forming System

1. Drug:

Independent of the dose form, medications must have certain properties in order to be applied topically via film-forming methods.  These medications are usually very strong, absorb quickly through the skin, are not very uncomfortable, and show some resistance to an enzyme found in the epidermis.  A drug's partition coefficient and other characteristics determine the skin penetration pathway it takes.  A drug's molecular weight affects how easily it can pass through human skin; smaller molecules have a tendency to penetrate more easily than larger ones.  (21)  Given the lipid-rich makeup of the stratum corneum, the medication should be able to penetrate it efficiently whether it is intended for topical or transdermal use. When opposed to their hydrophilic equivalents, medications having a strong lipophilic component typically have better skin penetration.  (56)

2.Permeation Enhancers:

Eutectic mixtures are commonly utilized to improve medication penetration. (24, 25, 66) One of the most potent eutectic compounds is a combination of camphor and menthol.  Since camphor and menthol combine to form a hydrophobic combination, they can be used as a penetration enhancer for drugs that are likewise hydrophobic.  On the other hand, camphor and menthol might promote pore formation and skin peeling.  The characteristic of a camphor and menthol blend is a warm sensation that progressively turns into a cold one.  (1) The eutectic mixture of camphor and menthol greatly increases the penetration of the antifungal drugs voriconazole, clotrimazole, and fluconazole in a Franz diffusion cell with nylon membranes. (24, 25, 66) Because camphor and menthol have hydrophobic properties, they can interact with the lipids in the stratum corneum to enhance drug penetration.  (1)

3.Plasticizers:

Plasticizers are primarily used in FFS to increase the film's flexibility and skin-adherence.  To create a transparent, flexible film that is low visible on skin, plasticizers are combined with polymers.  The concentration of plasticizers to be used in FFS cannot be determined by any other rule because the polymer determines the plasticizer's effectiveness.  The right amount of plasticizers will be used.  When too many plasticizers are used, the film becomes smooth but sticky, and when too few are used, the film becomes brittle and has poor skin adherence.  Plasticizers increase the film's tensile strength and reduce skin permeability to stop leaks.  A leak could accelerate the degradation of the film's qualities. PEG and PG are said to contribute to the increased absorption of antifungal drugs.  PG is useful for distributing drugs through the skin since it is a solubilizer in addition to being a plasticizer.  The concentration must be considered because PG significantly affects the viscosity of the film-forming fluid.  When coupled with ethanol or water, PG does not function well as a mixed solvent to prevent testosterone from crystallizing.  68  To improve drug penetration, less than 5% of PG is required.  Additionally, PEG 400 can boost the amount of film-forming solution sprayed.  As the concentration of PEG 400 rises, so does the amount per spray. Considering that PEG is a non-volatile solvent, this is linked to a drop in vapour pressure.  1, 27, 57

4.Solvents:

The solvents are one of the most important components of FFS.  It acts as a solubilizing agent for medications and polymers alike.  The solvent is not a true part of the coating that forms on skin because of its quick evaporation.  The only solvents used are those with a wide range of drug and polymer solubility.  FFS solvents should be highly volatile at skin surface temperature, enabling for rapid drying while leaving the drug and polymer (form film) behind.  The solvent's permeation-enhancing properties and direct impact on drug flux can promote drug transport through the skin, despite the extremely brief skin contact.  The solvent must disperse properly in order to establish a smooth, uniformly thick coating on the skin. Water cannot meet these solvent criteria, hence volatile organic solvents such ethanol, ethyl acetate, isopropanol, etc. that have a quick drying time and improved patient compliance (15,24,58) are used instead.

Solvents

Properties

Ethanol

organic solvent, volatile, hydrophilic

Isopropyl myristate

organic solvent, lipophilic, penetration enhancer

Water

hydrophilic

Isopropanol

organic solvent, volatile, hydrophilic

Acetone

organic solvent, volatile, hydrophilic

Butanol

organic solvent

5.Polymers

There are numerous types of polymers that may be utilized to build these systems, and the FFS uses them.  These polymers can be employed either by itself or in conjunction with other film-forming polymers to produce the desired film properties.  They fall primarily into two groups:                 

A. Natural and Semisynthetic Polymers

B. Synthetic Polymers

A. Natural and Semisynthetic Polymers

With water, cellulose and ethyl cellulose films are easily removed.  (66).  Eudragit is usually combined with ethyl cellulose at a concentration of 5.02 to 5.25% to produce films with superior properties.  According to reports, HPMC has a slow drying time.  (26, 25)  For the best film characteristics, the concentration should be 2%.  The films produced by HPMC at these concentrations are translucent, thin, and smooth.  78

A: Chitosan:

Apart from its film-forming capabilities, chitosan has antimicrobial, antioxidant, and mucoadhesive qualities that make it suitable for topical drug delivery.  (79).  Chitosan has a relatively high surface tension.  Chitosan is difficult to dissolve in water because of its surface tension, which increases with molecular weight and concentration.  Usually, surfactants are used to make chitosan more soluble.  (61) In making FFS from chitosan, Tween 80 can be used to reduce the surface tension. (81) The decrease in surface tension of chitosan goes hand in hand with an increase in the degree of deacetylation and its concentration, but the trend is not very significant. (81) The use of PEG 400 can also increase the stability and solubility of drugs in chitosan. Chitosan also has good conductivity with an increase in molecular weight so that it can be delivered using an electrostatic spray. Chitosan viscosity also decreases with increasing degrees of deacetylation. With these properties, chitosan can form films with denser droplet densities with smaller droplet diameters, ranging from 4–27 μm. Chitosan is also more hydrophilic at higher degrees (30–40 °C) such as on the skin and eyes. (82)

B: Xanthan Gum:

 According to study, xanthan gum's viscosity has a significant impact on its spray-ability.  The xanthan gum solution's surface tension and droplet size were both decreased by the addition of surfactants.  It's interesting to see that neither the viscosity nor the flow properties altered much.  Furthermore, when the concentration of xanthan gum increased, the spray angle and coverage area of the xanthan gum solution decreased.  (80)

Polymer

Concentration (%b/v)

API

Sprayer

Chitosan

0.5–1.5

--

ES

Ethyl cellulose

0.1–10

Ethanolic extract solution of Psoralea corylifolia seeds, ketoprofen, fluconazole, voriconazole, and clotrimazole

Ordinal

Xanthan gum

<0.5

--

Ordinal

Methylcellulose (Methocel®E5)

5

Testosterone

Ordinal

HPMC phthalate (HPMCP®50)

5

Testosterone

Ordinal

Na-CMC

0.5–2

Immuno-globuli

Ordinal

  1. Synthetic Polymers
  1. Carbopol:

Additionally, carbopol displays thixotropy flow properties. (83) Because carbopol can give or absorb wound moisture, it itself produces an amorphous hydrogel that is beneficial for open wounds. (84) Carbopol's viscoelastic nature permits deacetylation.  Its permeability to water vapor does not, however, correlate with its hydrophilic character.  In contrast to its elongation, chitosan's tensile strength will rise as its deacetylation levels rise.  (1)

b) Eudragit:

Eudragit is available in various types with different pur- poses for use. Generally, these synthetic polymers are used as additives to tablets for modifying drug release. (85) However, Eudragit is also known to increase drug permea- tion in the skin, (66,86,87) so that its application in topical preparations is widely developed. Eudragit EPO, Eudragit E 100, Eudragit S 100, Eudragit RL 100, and Eudragit RS 100 produce transparent and shiny films while Eudragit RSPO and RLPO do not. Films produced by Eudragit EPO, Eudragit E 100, Eudragit RL 100, and Eudragit RS 100 cannot be washed away with water. In contrast, Eudragit S100 provides film that can be removed with water after being applied to the skin.

The reason for this is because Eudragit S100 can dissolve at pH levels greater than 7.  Furthermore, Eudragit S100 doesn't cause skin irritation.  (22).  Reports state that Eudragit RS 100 has good sprayability, flexibility, and adhesiveness.  At a concentration of 10.05% in a mixture with 5.02% ethyl cellulose, Eudragit RLPO produces outstanding films; however, use over 15% may hinder water washability.  (24).

  1. Lutrol:

Although Lutrol F-127 generates a more consistent dose of the drug in each spray with a lower standard deviation, it shares film properties and spray patterns with Carbopol 940.  In comparison to Carbopol 940, Lutrol F-127 also creates films with superior drug release.  No complaints of skin irritation have been made.  (67)

  1. Plasdone:

 Plasdone is more effective than other polymers at increasing testosterone penetration, according to research by Lu et al. (27).  The sequence Plasdone > Eudragit EPO > PVP K30 > Eudragit RL was the most effective for testosterone penetration.  This resulted from the polymer's ability to prevent testosterone from crystallizing, which raises its flow.

Polymer

Concentration (%b/v)

API

Sprayer

Carbopol®940

0.05–1

Ketoprofen and oxybutynin

Ordinal and MDS

Carbopol®971P

0.25–0.5

Beta-1,3/1,6-glucan

Ordinal

Eudragit®EPO

5

Ropivacaine

MDS

Eudragit®E100

2–10

Clotrimazole, methylphenidate, ropivacaine and testosterone

Ordinal and MDS

Eudragit®L100-55

5

Testosterone

Ordinal

Eudragit®RSPO

5

Ropivacaine

MDS

Eudragit®RS100

5–15

Fluconazole, clotrimazole, methylphenidate, and testosterone

Ordinal andMDS

Eudragit®RLPO

5–15

Voriconazole, clotrimazole, and dexketoprofen

Ordinal andMDS

Plasdone®S630

5

Testosterone and dexketoprofen

MDS

Lutrol®F-127

0.05–0.2

Oxybutynin

MDS

Evaluation Tests:

  1. pH:

The pH value is checked and adjusted to improve the stability of the active component or make it suitable for the application site.  Diabetic wounds have a pH between 6.5-8, while burns heal faster below 7.32.  During the healing phase, the preparation's pH adjustment aims to prevent inflammation and changes in the wound's physiological state.  Furthermore, the amount of medication that penetrates the skin might be influenced by the dosage's level of ionization.  (1, 24, 31)

  1. Viscosity:

The density of the polymer will vary depending on its type and attention. This is an important characteristic, particularly in MDS, since the film forming result's density will impact its spreadability. The spray's content area can be dropped by adding the film- forming result's attention. ( 61)

  1. Film formation/Film flexibility:

Either a Petri dish or an excised rabbit skin is used to produce the films.  Film-formation, with or without precipitation of the film-forming polymer, is assessed and scored as complete and uniform, incomplete, or non-uniform.  The film's aesthetic qualities are described as opaque or transparent, sticky or dry, and peelable or not.  Stretching the skin in two or three directions allows for the evaluation of cracking and skin fixation, which are the basis for film flexibility.  If there is neither cracking nor skin fixation, the film is regarded as flexible; if both are present, it is rated as non-flexible.  (15)

  1. Evaporation time:

Another name for the evaporation period is the drying time.  The film's evaporation is measured to determine how quickly the film forms once the solution is sprayed.  To find the drying time, the cleaned petri dish was sprayed with the batch film-forming solution that had been tuned.  After a predetermined amount of time, a glass slide was placed stress-free on the film.  If there is no more moisture visible on the glass slide, the film is considered dry.  The rate of film formation is determined by the drying time.  After three iterations of this procedure, the average evaporation time was determined.  (13)

E)  In vitro Drug Penetration/Release Study:

 Franz diffusion cells are typically employed in this test as compartment separators together with cellulose membranes (pore size 0.45 m), nylon membranes (pore size 0.22 mm), or silicone membranes. The medium is phosphate buffer with a pH of 7.4. The film-forming solution is added to the donor compartment once the compartment system is prepared. At specific time intervals, a sample of the solution that diffuses through the cells is obtained, and the equipment is then used to measure it. Following the collection of samples, the same amount of fluid is replaced. (2,24,46)

 F)  Spray angle:

The solution (d) was sprayed horizontally onto a white sheet that was held 10 cm distant.  On the paper, the circumference of the circle was measured three times from various perspectives.  The diameter is used to calculate the radius (r).  The spray angle (θ) can be obtained using formula (65).                             

Spray angle (θ) = tan -1 (L/r)

Where, L = distance between sheet and spray nozzle.

R = radius of spray region

G)  Spray pattern:

By passing the spray through the TS onto white paper, the spray pattern was evaluated.  To aid in visibility, 1% methyl orange was dissolved in each formulation.  At a distance of 2.5 to 3.0 cm from the plate, the paper was clipped to the ship and sprayed with the mixture.  The diameters of the spots created by spray testing were measured and observed.  Each reading was averaged after this was done three times1.  (65).

H)  Average weight per dose:

The containers' initial weight was noted.  The containers were weighed once again after five successive deliveries were sprayed and foamed.  The average weight per dose was calculated by dividing the difference between the containers' original and final weights by the number of deliveries.  (66).

Average weight per dose (W)=Initial weight(W0)- Final weight(W1) /Number of deliveries.

 (I)Leak test:

This test assessed the pump seal's effectiveness and its capacity to hold the product's contents.  For three days, the filled container sunder test was kept upright at 30 degrees, and the contents were weighed both before and after the three days to make sure everything was in order.  the formulation leaking out of the container.  (66,)

Marketed product of film forming spray:

Product

Drug

Company

Formulation    type

Lamisil Once®

Terbinafine

hydrochloride

Novartis Consumer

Health,

Australasia, Pty Ltd

Film forming

Solution.

Axiron®

Testosterone

Lilly USA, LLC

Film forming

spray.

Medspray® the Patch-in-a Can®

Terbinafine

hydrochloride

Med Pharm Ltd, UK

Film forming

spray.

Liqui-Patch technology

Testosterone

hydrocortisone

Epinamics GmbH,

Germany

Film forming

spray.

Durapeel Technology

Ropivacane

Crescita

Therapeutics, Inc

Film forming gel

Pharma Dur® Technology

Hydroquinone

Polytherapeutics, Inc

Film forming

emulsion-gel

CONCLUSION:

FFS can be a promising drug delivery system with various benefits. Spray film-forming systems are modern drug delivery systems used for local, topical and transdermal delivery. Natural or synthetic polymers can be used as drug matrices and film formers following the need for increased stability and therapeutic effectiveness of the active sub- stance. Sprayers help form droplets with better and more uniform distribution and dosage of drugs.

REFERENCES

  1. Priyanka Mohite, Harshil Patel, Mansi Patel, Chainesh Shah, Umesh Upadhyay (2022). Film Forming Spray: A Comprehensive Review, International Journal of Innovative Science and Research Technology ISSN No: -2456-2165
  2. Umar, A. K., Butarbutar, M., Sriwidodo, S., & Wathoni, N. (2020). Film-forming sprays for topical drug delivery. Drug Design, Development and Therapy, 14, 2909–2925.
  3. Pünnel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):93.
  4. Prasit, M.R. and Langer, R., 2008. Transdermal drug delivery. Nature biotechnology, 26(11), pp.1261-1268.
  5. Sharma N, Agarwal G, Rana A, et al. A review: transdermal drug delivery system a tool for novel drug delivery system. Int J Drug Dev Res 2011; 3:70–84.
  6. Michaels, A.S., Chandrasekaran, S.K. and Shaw, J.E., 1975. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE journal, 21(5), pp.985-996.
  7. Sharadha M, Gowda DV, Vishal Gupta N, Akhila AR. An overview on topical drug delivery system – updated review. Int J Res Pharm Sci. 2020;11(1):368–385.
  8. Garg, T., Rath, G. and Goyal, A.K., 2015. Comprehensive review on additives of topical dosage forms for drug delivery. Drug delivery, 22(8), pp.969-987
  9. Panel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):932.
  10. Mandal, U.K., Chtterjee, B. and Pauzi, F.H.B., 2016. A Review on Transdermal Spray: Formulation Aspect. MJ Phar. 2 (1): 006. Citation: Mandal UK, Chtterjee B and Pauzi FHB. (2016). A Review on Transdermal Spray: Formulation Aspect. MJ Phar, 2(1), p.006.
  11. Tran, T.T. and Tran, P.H., 2019. Controlled release film forming systems in drug delivery: the potential for efficient drug delivery. Pharmaceutics, 11(6), p.290.
  12. McAuley, W.J. and Caserta, F., 2015. Film-forming and heated systems. Novel Delivery Systems for Transdermal and Intradermal Drug Delivery. Chichester, UK: John Wiley & Sons, Ltd, pp.97-124.
  13. Bodmeier R, Paeratakul O. Dry and wet strengths of polymeric films prepared from an aqueous colloidal polymer dispersion, Eudragit RS30D. International journal of pharmaceutics. 1993 Jul 31;96(1-3):129-38.
  14.  NN V, Saudagar RB. Formulation, development and evaluation of film-forming gel for prolonged dermal delivery of terbinafine hydrochloride.
  15. Anjali A Mali*, Vishnu Vasant Mali, Prashant Shamkuwar FILM FORMING SYSTEM: A REVIEW (2021) International Journal of Chemical & Pharmaceutical Analysis eISSN: 2348-0726; pISSN: 2395-2466.
  16. HimaniBajaj, Tirath Kumar, Vinod singh. Film Forming Gels: A Review. Research Journal of Pharmaceutical, Biological and chemical sciences, 2016; 7(4): 2085-2091.
  17. Harshakathhpalia ,kashmirakathe . film forming system for topical and transdermal delivery, Asian journal of pharmaceutical sciences. 2017; 12:487-497.
  18. Tran TTD, Tran PHL. Controlled release ?lm forming systems in drug delivery: the potential for ef?cient drug delivery. Pharmaceutics. 2019;11(6):290.
  19. Bornare, S.S.; Aher, S.S.; Saudagar, R.B. Film forming gel novel drug delivery system. Int. J. Curr. Pharm. Res. 2018, 10, 25.
  20.  B. Dhimmar, R. Pokale, M. Rahamathulla, et. al. Newfangled Topical Film Forming Solution for Facilitated Antifungal Therapy: Design, Development, Characterization and invitro Evaluation. Polymers; 2023 Vol 15,1003.
  21. Patel Hetvi D1, Dr. Chainesh Shah2, Dr. Umesh Upadhyay A Review on Topical Film Forming SprayInternational Journal of All Research Education and Scientific Methods (IJARESM), ISSN: 2455-6211
  22. Ranade S, Bajaj A, Londhe V, Babul N, Kao D. Fabrication of topical metered dose ?lm forming sprays for pain management. Eur J Pharm Sci. 2017; 100:132–141.
  23. Kathe K, Kathpalia H. Film forming systems for topical and trans- dermal drug delivery. Asian J Pharm Sci. 2017;12(6):487–497
  24. Gohel MC, Nagori SA. Fabrication of modi?ed transport furconazole transdermal spray containing ethyl cellulose and eudragit RS100 as ?lm formers. AAPS PharmSciTech.2009;10(2):684–691.
  25. Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of ?lm-forming voriconazole transdermal spray for the treatment of fungal infection. BullFac Pharmacy Cairo Univ.2017;55(1):41–51.
  26. Rajab NA. Preparation and evaluation of ketoprofen as dermal spray ?lm. Kerbala J Pharm Sci.2013; 6:1–8
  27. Lu W, Luo H, Wu Y, Zhu Z, Wang H. Preparation and character-ization of a metered dose transdermal spray for testosterone. Acta Pharm Sin B.2013;3(6):392–399.
  28. Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection. Bull Fac Pharmacy Cairo Univ. 2017;55(1):41–51.
  29. Urkan E, Guler H, Komekci F. A review of electrostatic spraying for agricultural applications. Tarim Makinalari Bilim Derg. 2016;12 (4):229–233.
  30. Umar AK, Sriwidodo S, Maksum IP, Wathoni N. Film-forming spray of water-soluble chitosan containing liposome-coated human epidermal growth factor for wound healing. Molecules. 2021 Sep 2;26(17):5326.
  31. Zurdo Schroeder I, Franke P, Schaefer UF, Lehr C-M. Development and characterization of film forming polymeric solutions for skin drug delivery. Eur J Pharm Biopharm 2007; 65:111–21.
  32. Desai, Mrunal, et al. "Design, development, and characterization of film forming spray as novel antifungal topical formulation for superficial fungal infections." Indian J. Pharm, Educat. Res 56 (2022): s651-s658.
  33. Patel, Harshil M., et al. "Fabrication and Characterization of Luliconazole Film-Forming Topical Spray for the Treatment of Fungal Infections." Manipal Journal of Pharmaceutical Sciences 6.2 (2020).
  34. Sahane MD, Gaikwad MY, Gaikar DS. Spray: Film Forming System Promising as Transdermal Drug Delivery System. Int J Pharm Sci. 2024.
  35. Azad H, Dwivedi A, Darwhekar GN. A Review on Topical Film Forming Spray. International Journal of Pharmacy & Life Sciences. 2024 Dec 1;15(12).
  36. Sahane MD, Gaikwad MY, Gaikar DS. Spray: Film Forming System Promising as Transdermal Drug Delivery System. Int J Pharm Sci. 2024.
  37. Al-Jarsha HY, Ghareeb MM, Hussein AA. A review on film forming drug delivery systems. Research Journal of Pharmacy and Technology. 2021;14(10):5579-88.
  38. Zhong Y, Zhuang C, Gu W, Zhao Y. Effect of molecular weight on the properties of chitosan films prepared using electrostatic spraying technique. Carbohydr Polym. 2019; 212: 197–205.
  39. Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Ghoneim AM. Rapid pain relief using transdermal film forming polymeric solution of ketorolac. Pharmaceutical development and technology. 2013 Oct 1;18(5):1005-16.
  40. Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray Film-Forming systems as promising topical in situ Systems: A review. Saudi Pharmaceutical Journal. 2023 Jan 1;31(1):154 69.
  41. Wayal V, Nagasree K, Vishwanath BA. Design, development and evaluation of silk-based film forming spray for wound healing. Journal of Drug Delivery and Therapeutics. 2021 Jun 15;11(3-S):15-8.
  42. Soujith NB, Jawahar N. Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2023 Jan 1;57(1): S85-97.
  43. Chamsai B, Soodvilai S, Opanasopit P, Samprasit W. Topical Film Forming Chlorhexidine Gluconate Sprays for Antiseptic Application. Pharmaceutics. 2022 May 25;14(6):1124.
  44. Pünnel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):932.
  45. Zurdo Schroeder I, Franke P, Schaefer UF, Lehr C-M. Development and characterization of film forming polymeric solutions for skin drug delivery. Eur J Pharm Biopharm. 2007;65(1):111–121.
  46. Kwon S-I, Kyung K-H, Park J-Y, et al. Uniform anti-reflective films fabricated by layer-by-layer ultrasonic spray method. Colloids Surf a Physicoc hem Eng Asp. 2019;580((August):123785):123785.
  47. Frederiksen K, Guy RH, Petersson K. The potential of polymeric f ilm-forming systems as sustained delivery platforms for topical drugs. Expert Opin Drug Deliv. 2016;13(3):349–360.
  48. Deshmukh SN, Gade V, Garud A, Dumbre R, Warude B, Maharaj S, Girme S, Shewalkar S. Novel film forming spray from tea tree leaves with special emphasis on development, formulation and evaluation. Journal of Positive School Psychology. 2022 Jun 1:5179-84.
  49. Desai M, Godbole AM, Somnache S, Gajare P, Pednekar A, Manerikar S, Kudaskar K, Naik V. Design, Development, and Characterization of Film Forming Spray as Novel Antifungal Topical Formulation for Superficial Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2022 Oct 1;56(4): S651-8.
  50. Soujith NB, Jawahar N. Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2023 Jan 1;57(1): S85-97.
  51. J. Saravanan, K. Elango, S. Daisy Chellakumari and K. Arulkumar. Formulation and Evaluation of film forming gel of diclofenac diethylamine, world journal of pharmacy and pharmaceutical sciences .2018;6:1106-1117.
  52. Harshakathhpalia, kashmirakathe. film forming system for topical and transdermal delivery, Asian journal of pharmaceutical sciences. 2017; 12:487-497.
  53. Sameeksha Mhatre, Nitin Kolhe, Bhagyashree Chavan, wiShah Kashif. A REVIEW ON FILM-FORMING SPRAY SOLUTIONS 2023 IJCRT ISSN: 2320-2882.
  54. Shital K. Tilekar*, Sadikali F. Sayyad and Bharati K. Phopse A COMPREHENSIVE REVIEW ON FILM FORMING TOPICAL SPRAY DRUG DELIVERY, World Journal of Pharmacy and Pharmaceutical Sciences, ISSN 2278 – 4357.
  55. de Oliveira FF, de Menezes LR, Tavares MI. Film-forming systems in topically administered pharmaceutical formulations. Materials Sciences and Applications. 2020 Aug 14;11(08):576.
  56. Karki, S., Kim, H., Na, S.J., Shin, D., Jo, K. and Lee, J., 2016. Thin films as an emerging platform for drug delivery. asian journal of pharmaceutical sciences, 11(5), pp.559-574.
  57. Bishop SM, Walker M, Rogers AA, Chen WYJ. Importance of moisture balance at the wound dressing interface. J Wound Care. 2003;12(4):125.
  58. Frederiksen K, Guy RH, Petersson K. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 91 :9-15.
  59. Williams AC, Walters KA. Chemical penetration enhancement: possibilities and problems. In: Walters KA, Roberts MS, editors. Dermatologic, cosmeceutic, and cosmetic development: therapeutic and novel approaches. New York: Informa Healthcare; 2007.
  60. Felton LA. Film coating of oral solid dosage forms. Encyclopedia of pharmaceutical technology. 2007; 3:1729-747.
  61. Zhong Y, Zhuang C, Gu W, Zhao Y. Effect of molecular weight on the properties of chitosan films prepared using electrostatic spraying technique. Carbohydrate Polymer. 2019;212(May2018):197 205.
  62. Tran TTD, Tran PHL. Controlled release film forming systems in drug delivery: the potential for efficient drug delivery. Pharmaceutics. 2019;11(6):290
  63. Geh KJ, Stelzl A, Gröne A, Wagner L, Förster B, Winter G., Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies. Eur J Pharm Biopharm. 2019;142 (November2018):123–132.
  64. Sveikauskait? I, Briedis V. Effect of film-forming polymers on release of naftifine hydrochloride from nail lacquers. International Journal of Polymer Science. 2017; 1-7. 12.
  65. Nidamanuri Bala Sai Soujith, Natarajan Jawahar*Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections, Indian Journal of Pharmaceutical Education and Research, 2023; 57(1s): s85-s97.
  66. Mansi Paradkar, Vaishali Thakkar, Tejal Soni, Tejal Gandhi, and Mukesh Gohel, Formulation and evaluation of clotrimazole transdermal spray, Drug development and industrial pharmacy41(10),1718-1725,2015.
  67. Bakshi A, Bajaj A, Malhotra G, et al. A novel metered dose transdermal spray formulation for oxybutynin. Indian J Pharm Sci 2008; 70:733.
  68. Tan, X., Feldman, S.R., Chang, J. and Balkrishnan, R., 2012. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert opinion on drug delivery, 9(10), pp.1263 1271.
  69. Schlüter H, Wepf R, Moll I, Franke WW. Sealing the live part of the skin: the integrated meshwork of desmosomes, tight junctions and curvilinear ridge structures in the cells of the uppermost granular layer of the human epidermis. European journal of cell biology. 2004 Jan 1;83(11-12):655-65.
  70. Elias, P.M., 2005. Stratum corneum defensive functions: an integrated view. Journal of Investigative Dermatology, 125(2), pp.183-200
  71. Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D. Adherence to topical treatment in psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 2012 May; 26:61-7.
  72. Ruela ALM, Perissinato AG. Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian J Pharm Sci. 2016;52(3):527–544.
  73. Ibrahim SA. Spray-on transdermal drug delivery systems. Expert Opin Drug Deliv. 2015;12(2):195 205. doi:10.1517/17425247.2015. 961419.
  74. Hakim M, Walia H, Rafiq M, Grannell T, Cartabuke RS, Tobias JD. Oxymetazoline metered dose spray: factors affecting delivery volume. J Pediatr Pharmacol Ther. 2016;21(3):247–251.
  75. Ru Y, Gan Y, Zheng J, Zhou H. Design and experiments on droplet charging device for high-range electrostatic sprayer. Am Soc Agric Biol Eng Annu Int Meet 2008. 2008;1:561–571.
  76. Barringer SA, Sumonsiri N. Electrostatic coating technologies for food processing. Annu Rev Food Sci Technol. 2015;6(1):157–169. doi:10.1146/annurev-food-022814-015526
  77. Abu-Ali J, Barringer SA. Method for electrostatic atomization of emulsions in an EHD system. J Electrostat. 2005;63(5):361–369. doi:10.1016/j.elstat.2004.11.004
  78. Saingam W, Chankana N, Madaka F, Sueree L, Homchuam S. Formulation development of topical film formimg spray from Piper nigrum L. Thai J Pharm Sci. 2018;42(supplement):93–97
  79. Kahya N. Water soluble chitosan derivatives and their biological activities: a review. Polym Sci. 2018; 4(2):1–11.
  80. Wang S, He X, Song J, Wang S, Jia X, Ling Y. Effects of xanthan gum on atomization and deposition characteristics in water and Silwet 408 aqueous solution. Int J Agric Biol Eng. 2018;11 (3):29–34.
  81. ZhuangC,ZhongY,ZhaoY.Effectofdeacetylationdegreeonproper ties of Chitosan films using electrostatic spraying technique. Food Control. 2019;97:25–31.
  82. Sriwidodo, Subroto T, Maksum IP, Subarnas A, et al. Preparation and optimization of chitosan-hegf nanoparticle using ionic gelation method stabilized by polyethylene glycol (PEG) for wound healing therapy. Int J Res Pharm Sci. 2020;11(1):1220–1230.
  83. Varges PR, Costa CM, Fonseca BS, Naccache MF, Mendes PRDS. Rheological characterization of carbopol® dispersions in water and in water/glycerol solutions. Fluids. 2019;4(3):1–20. doi:10.3390/ f luids4010003
  84. Grip J, Engstad RE, Skjæveland I, Škalko-Basnet N, Holsæter AM. Sprayable Carbopol hydrogel with soluble beta-1,3/1,6-glucan as an active ingredient for wound healing– development and in-vivo evaluation. Eur J Pharm Sci. 2017;107(April):24–31. doi:10.1016/ j.ejps.2017.06.029
  85. Patra CN, Priya R, Swain S, Kumar Jena G, Panigrahi KC, Ghose D. Pharmaceutical significance of Eudragit: a review. Futur J Pharm Sci. 2017;3(1):33–45.
  86. Nandy B, Mazumder B. Formulation and characterizations of delayed release multi-particulates system of indomethacin: optimi zation by response surface methodology. Curr Drug Deliv. 2014;11 (1):72–86.
  87. Nandy B, Mazumder B. Formulation and characterizations of delayed release multi-particulates system of indomethacin: optimi zation by response surface methodology. Curr Drug Deliv. 2014;11 (1):72–86.
  88. Gohli T, Shah P. Formulation and development of transdermal spray of ibandronate sodium. 2019;1.

Reference

  1. Priyanka Mohite, Harshil Patel, Mansi Patel, Chainesh Shah, Umesh Upadhyay (2022). Film Forming Spray: A Comprehensive Review, International Journal of Innovative Science and Research Technology ISSN No: -2456-2165
  2. Umar, A. K., Butarbutar, M., Sriwidodo, S., & Wathoni, N. (2020). Film-forming sprays for topical drug delivery. Drug Design, Development and Therapy, 14, 2909–2925.
  3. Pünnel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):93.
  4. Prasit, M.R. and Langer, R., 2008. Transdermal drug delivery. Nature biotechnology, 26(11), pp.1261-1268.
  5. Sharma N, Agarwal G, Rana A, et al. A review: transdermal drug delivery system a tool for novel drug delivery system. Int J Drug Dev Res 2011; 3:70–84.
  6. Michaels, A.S., Chandrasekaran, S.K. and Shaw, J.E., 1975. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE journal, 21(5), pp.985-996.
  7. Sharadha M, Gowda DV, Vishal Gupta N, Akhila AR. An overview on topical drug delivery system – updated review. Int J Res Pharm Sci. 2020;11(1):368–385.
  8. Garg, T., Rath, G. and Goyal, A.K., 2015. Comprehensive review on additives of topical dosage forms for drug delivery. Drug delivery, 22(8), pp.969-987
  9. Panel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):932.
  10. Mandal, U.K., Chtterjee, B. and Pauzi, F.H.B., 2016. A Review on Transdermal Spray: Formulation Aspect. MJ Phar. 2 (1): 006. Citation: Mandal UK, Chtterjee B and Pauzi FHB. (2016). A Review on Transdermal Spray: Formulation Aspect. MJ Phar, 2(1), p.006.
  11. Tran, T.T. and Tran, P.H., 2019. Controlled release film forming systems in drug delivery: the potential for efficient drug delivery. Pharmaceutics, 11(6), p.290.
  12. McAuley, W.J. and Caserta, F., 2015. Film-forming and heated systems. Novel Delivery Systems for Transdermal and Intradermal Drug Delivery. Chichester, UK: John Wiley & Sons, Ltd, pp.97-124.
  13. Bodmeier R, Paeratakul O. Dry and wet strengths of polymeric films prepared from an aqueous colloidal polymer dispersion, Eudragit RS30D. International journal of pharmaceutics. 1993 Jul 31;96(1-3):129-38.
  14.  NN V, Saudagar RB. Formulation, development and evaluation of film-forming gel for prolonged dermal delivery of terbinafine hydrochloride.
  15. Anjali A Mali*, Vishnu Vasant Mali, Prashant Shamkuwar FILM FORMING SYSTEM: A REVIEW (2021) International Journal of Chemical & Pharmaceutical Analysis eISSN: 2348-0726; pISSN: 2395-2466.
  16. HimaniBajaj, Tirath Kumar, Vinod singh. Film Forming Gels: A Review. Research Journal of Pharmaceutical, Biological and chemical sciences, 2016; 7(4): 2085-2091.
  17. Harshakathhpalia ,kashmirakathe . film forming system for topical and transdermal delivery, Asian journal of pharmaceutical sciences. 2017; 12:487-497.
  18. Tran TTD, Tran PHL. Controlled release ?lm forming systems in drug delivery: the potential for ef?cient drug delivery. Pharmaceutics. 2019;11(6):290.
  19. Bornare, S.S.; Aher, S.S.; Saudagar, R.B. Film forming gel novel drug delivery system. Int. J. Curr. Pharm. Res. 2018, 10, 25.
  20.  B. Dhimmar, R. Pokale, M. Rahamathulla, et. al. Newfangled Topical Film Forming Solution for Facilitated Antifungal Therapy: Design, Development, Characterization and invitro Evaluation. Polymers; 2023 Vol 15,1003.
  21. Patel Hetvi D1, Dr. Chainesh Shah2, Dr. Umesh Upadhyay A Review on Topical Film Forming SprayInternational Journal of All Research Education and Scientific Methods (IJARESM), ISSN: 2455-6211
  22. Ranade S, Bajaj A, Londhe V, Babul N, Kao D. Fabrication of topical metered dose ?lm forming sprays for pain management. Eur J Pharm Sci. 2017; 100:132–141.
  23. Kathe K, Kathpalia H. Film forming systems for topical and trans- dermal drug delivery. Asian J Pharm Sci. 2017;12(6):487–497
  24. Gohel MC, Nagori SA. Fabrication of modi?ed transport furconazole transdermal spray containing ethyl cellulose and eudragit RS100 as ?lm formers. AAPS PharmSciTech.2009;10(2):684–691.
  25. Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of ?lm-forming voriconazole transdermal spray for the treatment of fungal infection. BullFac Pharmacy Cairo Univ.2017;55(1):41–51.
  26. Rajab NA. Preparation and evaluation of ketoprofen as dermal spray ?lm. Kerbala J Pharm Sci.2013; 6:1–8
  27. Lu W, Luo H, Wu Y, Zhu Z, Wang H. Preparation and character-ization of a metered dose transdermal spray for testosterone. Acta Pharm Sin B.2013;3(6):392–399.
  28. Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection. Bull Fac Pharmacy Cairo Univ. 2017;55(1):41–51.
  29. Urkan E, Guler H, Komekci F. A review of electrostatic spraying for agricultural applications. Tarim Makinalari Bilim Derg. 2016;12 (4):229–233.
  30. Umar AK, Sriwidodo S, Maksum IP, Wathoni N. Film-forming spray of water-soluble chitosan containing liposome-coated human epidermal growth factor for wound healing. Molecules. 2021 Sep 2;26(17):5326.
  31. Zurdo Schroeder I, Franke P, Schaefer UF, Lehr C-M. Development and characterization of film forming polymeric solutions for skin drug delivery. Eur J Pharm Biopharm 2007; 65:111–21.
  32. Desai, Mrunal, et al. "Design, development, and characterization of film forming spray as novel antifungal topical formulation for superficial fungal infections." Indian J. Pharm, Educat. Res 56 (2022): s651-s658.
  33. Patel, Harshil M., et al. "Fabrication and Characterization of Luliconazole Film-Forming Topical Spray for the Treatment of Fungal Infections." Manipal Journal of Pharmaceutical Sciences 6.2 (2020).
  34. Sahane MD, Gaikwad MY, Gaikar DS. Spray: Film Forming System Promising as Transdermal Drug Delivery System. Int J Pharm Sci. 2024.
  35. Azad H, Dwivedi A, Darwhekar GN. A Review on Topical Film Forming Spray. International Journal of Pharmacy & Life Sciences. 2024 Dec 1;15(12).
  36. Sahane MD, Gaikwad MY, Gaikar DS. Spray: Film Forming System Promising as Transdermal Drug Delivery System. Int J Pharm Sci. 2024.
  37. Al-Jarsha HY, Ghareeb MM, Hussein AA. A review on film forming drug delivery systems. Research Journal of Pharmacy and Technology. 2021;14(10):5579-88.
  38. Zhong Y, Zhuang C, Gu W, Zhao Y. Effect of molecular weight on the properties of chitosan films prepared using electrostatic spraying technique. Carbohydr Polym. 2019; 212: 197–205.
  39. Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Ghoneim AM. Rapid pain relief using transdermal film forming polymeric solution of ketorolac. Pharmaceutical development and technology. 2013 Oct 1;18(5):1005-16.
  40. Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray Film-Forming systems as promising topical in situ Systems: A review. Saudi Pharmaceutical Journal. 2023 Jan 1;31(1):154 69.
  41. Wayal V, Nagasree K, Vishwanath BA. Design, development and evaluation of silk-based film forming spray for wound healing. Journal of Drug Delivery and Therapeutics. 2021 Jun 15;11(3-S):15-8.
  42. Soujith NB, Jawahar N. Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2023 Jan 1;57(1): S85-97.
  43. Chamsai B, Soodvilai S, Opanasopit P, Samprasit W. Topical Film Forming Chlorhexidine Gluconate Sprays for Antiseptic Application. Pharmaceutics. 2022 May 25;14(6):1124.
  44. Pünnel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021 Jun 23;13(7):932.
  45. Zurdo Schroeder I, Franke P, Schaefer UF, Lehr C-M. Development and characterization of film forming polymeric solutions for skin drug delivery. Eur J Pharm Biopharm. 2007;65(1):111–121.
  46. Kwon S-I, Kyung K-H, Park J-Y, et al. Uniform anti-reflective films fabricated by layer-by-layer ultrasonic spray method. Colloids Surf a Physicoc hem Eng Asp. 2019;580((August):123785):123785.
  47. Frederiksen K, Guy RH, Petersson K. The potential of polymeric f ilm-forming systems as sustained delivery platforms for topical drugs. Expert Opin Drug Deliv. 2016;13(3):349–360.
  48. Deshmukh SN, Gade V, Garud A, Dumbre R, Warude B, Maharaj S, Girme S, Shewalkar S. Novel film forming spray from tea tree leaves with special emphasis on development, formulation and evaluation. Journal of Positive School Psychology. 2022 Jun 1:5179-84.
  49. Desai M, Godbole AM, Somnache S, Gajare P, Pednekar A, Manerikar S, Kudaskar K, Naik V. Design, Development, and Characterization of Film Forming Spray as Novel Antifungal Topical Formulation for Superficial Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2022 Oct 1;56(4): S651-8.
  50. Soujith NB, Jawahar N. Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections. Indian Journal of Pharmaceutical Education and Research. 2023 Jan 1;57(1): S85-97.
  51. J. Saravanan, K. Elango, S. Daisy Chellakumari and K. Arulkumar. Formulation and Evaluation of film forming gel of diclofenac diethylamine, world journal of pharmacy and pharmaceutical sciences .2018;6:1106-1117.
  52. Harshakathhpalia, kashmirakathe. film forming system for topical and transdermal delivery, Asian journal of pharmaceutical sciences. 2017; 12:487-497.
  53. Sameeksha Mhatre, Nitin Kolhe, Bhagyashree Chavan, wiShah Kashif. A REVIEW ON FILM-FORMING SPRAY SOLUTIONS 2023 IJCRT ISSN: 2320-2882.
  54. Shital K. Tilekar*, Sadikali F. Sayyad and Bharati K. Phopse A COMPREHENSIVE REVIEW ON FILM FORMING TOPICAL SPRAY DRUG DELIVERY, World Journal of Pharmacy and Pharmaceutical Sciences, ISSN 2278 – 4357.
  55. de Oliveira FF, de Menezes LR, Tavares MI. Film-forming systems in topically administered pharmaceutical formulations. Materials Sciences and Applications. 2020 Aug 14;11(08):576.
  56. Karki, S., Kim, H., Na, S.J., Shin, D., Jo, K. and Lee, J., 2016. Thin films as an emerging platform for drug delivery. asian journal of pharmaceutical sciences, 11(5), pp.559-574.
  57. Bishop SM, Walker M, Rogers AA, Chen WYJ. Importance of moisture balance at the wound dressing interface. J Wound Care. 2003;12(4):125.
  58. Frederiksen K, Guy RH, Petersson K. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 91 :9-15.
  59. Williams AC, Walters KA. Chemical penetration enhancement: possibilities and problems. In: Walters KA, Roberts MS, editors. Dermatologic, cosmeceutic, and cosmetic development: therapeutic and novel approaches. New York: Informa Healthcare; 2007.
  60. Felton LA. Film coating of oral solid dosage forms. Encyclopedia of pharmaceutical technology. 2007; 3:1729-747.
  61. Zhong Y, Zhuang C, Gu W, Zhao Y. Effect of molecular weight on the properties of chitosan films prepared using electrostatic spraying technique. Carbohydrate Polymer. 2019;212(May2018):197 205.
  62. Tran TTD, Tran PHL. Controlled release film forming systems in drug delivery: the potential for efficient drug delivery. Pharmaceutics. 2019;11(6):290
  63. Geh KJ, Stelzl A, Gröne A, Wagner L, Förster B, Winter G., Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies. Eur J Pharm Biopharm. 2019;142 (November2018):123–132.
  64. Sveikauskait? I, Briedis V. Effect of film-forming polymers on release of naftifine hydrochloride from nail lacquers. International Journal of Polymer Science. 2017; 1-7. 12.
  65. Nidamanuri Bala Sai Soujith, Natarajan Jawahar*Terbinafine HCl Film-Forming Spray for the Treatment of Topical Fungal Infections, Indian Journal of Pharmaceutical Education and Research, 2023; 57(1s): s85-s97.
  66. Mansi Paradkar, Vaishali Thakkar, Tejal Soni, Tejal Gandhi, and Mukesh Gohel, Formulation and evaluation of clotrimazole transdermal spray, Drug development and industrial pharmacy41(10),1718-1725,2015.
  67. Bakshi A, Bajaj A, Malhotra G, et al. A novel metered dose transdermal spray formulation for oxybutynin. Indian J Pharm Sci 2008; 70:733.
  68. Tan, X., Feldman, S.R., Chang, J. and Balkrishnan, R., 2012. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert opinion on drug delivery, 9(10), pp.1263 1271.
  69. Schlüter H, Wepf R, Moll I, Franke WW. Sealing the live part of the skin: the integrated meshwork of desmosomes, tight junctions and curvilinear ridge structures in the cells of the uppermost granular layer of the human epidermis. European journal of cell biology. 2004 Jan 1;83(11-12):655-65.
  70. Elias, P.M., 2005. Stratum corneum defensive functions: an integrated view. Journal of Investigative Dermatology, 125(2), pp.183-200
  71. Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D. Adherence to topical treatment in psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 2012 May; 26:61-7.
  72. Ruela ALM, Perissinato AG. Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian J Pharm Sci. 2016;52(3):527–544.
  73. Ibrahim SA. Spray-on transdermal drug delivery systems. Expert Opin Drug Deliv. 2015;12(2):195 205. doi:10.1517/17425247.2015. 961419.
  74. Hakim M, Walia H, Rafiq M, Grannell T, Cartabuke RS, Tobias JD. Oxymetazoline metered dose spray: factors affecting delivery volume. J Pediatr Pharmacol Ther. 2016;21(3):247–251.
  75. Ru Y, Gan Y, Zheng J, Zhou H. Design and experiments on droplet charging device for high-range electrostatic sprayer. Am Soc Agric Biol Eng Annu Int Meet 2008. 2008;1:561–571.
  76. Barringer SA, Sumonsiri N. Electrostatic coating technologies for food processing. Annu Rev Food Sci Technol. 2015;6(1):157–169. doi:10.1146/annurev-food-022814-015526
  77. Abu-Ali J, Barringer SA. Method for electrostatic atomization of emulsions in an EHD system. J Electrostat. 2005;63(5):361–369. doi:10.1016/j.elstat.2004.11.004
  78. Saingam W, Chankana N, Madaka F, Sueree L, Homchuam S. Formulation development of topical film formimg spray from Piper nigrum L. Thai J Pharm Sci. 2018;42(supplement):93–97
  79. Kahya N. Water soluble chitosan derivatives and their biological activities: a review. Polym Sci. 2018; 4(2):1–11.
  80. Wang S, He X, Song J, Wang S, Jia X, Ling Y. Effects of xanthan gum on atomization and deposition characteristics in water and Silwet 408 aqueous solution. Int J Agric Biol Eng. 2018;11 (3):29–34.
  81. ZhuangC,ZhongY,ZhaoY.Effectofdeacetylationdegreeonproper ties of Chitosan films using electrostatic spraying technique. Food Control. 2019;97:25–31.
  82. Sriwidodo, Subroto T, Maksum IP, Subarnas A, et al. Preparation and optimization of chitosan-hegf nanoparticle using ionic gelation method stabilized by polyethylene glycol (PEG) for wound healing therapy. Int J Res Pharm Sci. 2020;11(1):1220–1230.
  83. Varges PR, Costa CM, Fonseca BS, Naccache MF, Mendes PRDS. Rheological characterization of carbopol® dispersions in water and in water/glycerol solutions. Fluids. 2019;4(3):1–20. doi:10.3390/ f luids4010003
  84. Grip J, Engstad RE, Skjæveland I, Škalko-Basnet N, Holsæter AM. Sprayable Carbopol hydrogel with soluble beta-1,3/1,6-glucan as an active ingredient for wound healing– development and in-vivo evaluation. Eur J Pharm Sci. 2017;107(April):24–31. doi:10.1016/ j.ejps.2017.06.029
  85. Patra CN, Priya R, Swain S, Kumar Jena G, Panigrahi KC, Ghose D. Pharmaceutical significance of Eudragit: a review. Futur J Pharm Sci. 2017;3(1):33–45.
  86. Nandy B, Mazumder B. Formulation and characterizations of delayed release multi-particulates system of indomethacin: optimi zation by response surface methodology. Curr Drug Deliv. 2014;11 (1):72–86.
  87. Nandy B, Mazumder B. Formulation and characterizations of delayed release multi-particulates system of indomethacin: optimi zation by response surface methodology. Curr Drug Deliv. 2014;11 (1):72–86.
  88. Gohli T, Shah P. Formulation and development of transdermal spray of ibandronate sodium. 2019;1.

Photo
Rutuja Patange
Corresponding author

Department Of Pharmaceutics JSPM Sudhakarrao Naik Institute of Pharmacy Pusad. India 445204.

Photo
Ravikiran Wakade
Co-author

Department Of Pharmaceutics JSPM Sudhakarrao Naik Institute of Pharmacy Pusad. India 445204.

Rutuja Patange*, Ravikiran Wakade, Review on Film Forming Spray for Topical Drug Delivery, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 3056-3071. https://doi.org/10.5281/zenodo.16312050

More related articles
Formulation & Evaluation Of Herbal Sunscreen In Co...
Rutuja Golecha , Dr Vaishali Kate , Dr. Santosh Payghan , ...
A Review Article On: An Approach Towards Plant Lay...
Tambe Gaurav , Thete Sayali, Tambe Tanushka, Vadak Prachi, Dr. S...
Engineered Nanofiber Based Carrier to Manage Arthr...
Dr. Omprakash Bhusnure, Vedant Mane, Shivam Vyavahare, Dr. Mani G...
A Comprehensive Review On: Barleria Cristata Linn. (Acanthaceae)...
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
Artificial Intelligence in Pharmacy: A Comprehensive Review of Applications, Dru...
Harshada Patil, Akshada Deshmukh, Komal Patil, Amruta Patil, Aishwarya Patil, Ishwari Nimbalkar, ...
Formulation and Evaluation of Herbal Mouth Ulcer Gel by Utilizing Psidium Guajav...
Shubham Tomar , Akash Gorase , Prathamesh Ware , Krushna Jagzap , Rushikesh Shinde , ...
Related Articles
Formulation, Development and Evaluation of Lip Serum...
A. S. Jadhav, P. B. Sutar, Dr. S. K. Mohite, ...
Formulation And Evaluation Of Herbal Gel...
Rituraj Rajjan Singh, Somprabha Madhukar, Shruti Rathore, ...
Comprehensive Review on Nanostructured Lipid Carriers...
Dr. Shaikh Nasheer, Limaye Akhilesh, Humnabade Shital, Anantwal Akshat, Babhulkar Akshay, Joshi Maha...
Hormonal Fluctuations and Their Impact on Migraine Susceptibility in Women...
Minal Kumbhar, Dr. N. S. Naikwade, Aarti Mole, Janhvi Mali, ...
Formulation & Evaluation Of Herbal Sunscreen In Combination With Olive Oil Usefu...
Rutuja Golecha , Dr Vaishali Kate , Dr. Santosh Payghan , ...
More related articles
Formulation & Evaluation Of Herbal Sunscreen In Combination With Olive Oil Usefu...
Rutuja Golecha , Dr Vaishali Kate , Dr. Santosh Payghan , ...
A Review Article On: An Approach Towards Plant Layout...
Tambe Gaurav , Thete Sayali, Tambe Tanushka, Vadak Prachi, Dr. S. D. Mankar, ...
Engineered Nanofiber Based Carrier to Manage Arthritis and Inflammation...
Dr. Omprakash Bhusnure, Vedant Mane, Shivam Vyavahare, Dr. Mani Ganesh , S. G. Zingade, Dr. Vijayend...
Formulation & Evaluation Of Herbal Sunscreen In Combination With Olive Oil Usefu...
Rutuja Golecha , Dr Vaishali Kate , Dr. Santosh Payghan , ...
A Review Article On: An Approach Towards Plant Layout...
Tambe Gaurav , Thete Sayali, Tambe Tanushka, Vadak Prachi, Dr. S. D. Mankar, ...
Engineered Nanofiber Based Carrier to Manage Arthritis and Inflammation...
Dr. Omprakash Bhusnure, Vedant Mane, Shivam Vyavahare, Dr. Mani Ganesh , S. G. Zingade, Dr. Vijayend...